SUMMARY Trends in annual hospital admission rates for asthma in the 0 to 14 year age group were examined in New Zealand, England and Wales, the United States, Canada, and Australia. There has been a striking increase in hospital admissions for asthma in children in all these countries since the mid 1960s.
Hospital admission rates for asthma have increased noticeably since the mid 1960s in New Zealand.' In the 0 to 14 year age group admissions have increased -10 foTld in 15 years (63 per 100 000 in 1966 to 629 per 100 000 in 1981). An increase in hospital admissions for asthma in children in England and Wales has also been noted.2 As part of an investigation into possible explanations for this increase, trends in annual hospital admission rates for asthma in New Zealand children were compared with those of other countries. The number of hospital admissions due to asthma in children and the considerable increase in admissions seen in all countries examined indicates that asthma is a major health problem for the child, its family, and the community. Case 1 A girl of 36 weeks' gestation, who weighed only 1015 g at birth, developed a conjugated hyperbilirubinaemia from her third day of life. Her mother had had a non-specific viral illness with a rash at about 24 to 26 weeks' gestation.
Investigation showed evidence of cytomegalovirus infection in urine culture and throat swab. Both mother and child had a cytomegalovirus titre of 40 by complement fixation. Other virology and toxoplasma titres were negative. In addition she had an a1-antitrypsin titre of 1-7 g/l (normal range 1-8 to 3-0 g/l) with a PiMZ phenotype, despite both parents being PiM. She reverted to a PiM phenotype by the age of 11 months.
Her developmental progress has been mildly delayed with bilateral hearing impairment and poor growth. There is no evidence of persisting hepatic pathology at the age of 2 years. Investigation showed a normal hepatic ultrasound, negative virology and toxoplasma titres, and negative urine culture for cytomegalovirus. The urine showed no notable increase in reducing substances. His a,-antitrypsin value was 1-3 g/l (normal range 1-8 to 3-0 g/l) with a PiMZ phenotype. His parents' phenotypes were P1M. During the convalescent phase, at the age of 10 months, when his liver function tests had returned to normal, his phenotype reverted to P1M with an a1-antitrypsin value of 1-9 g/l.
He has persisting poor growth, but his development seems to be progressing satisfactorily. 
